22/05/2013 13:49:11
22/05/2013 13:49:11
| Name | Symbol | Market | Type | ISIN | Description |
|---|---|---|---|---|---|
| Summit Corporation | LSE:SUMM | London | Ordinary Share | GB00B02T3K57 | ORD 1P |
| Change | Change % | Cur | Bid | Offer | High | Low | Open | Volume | Time | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.25 | -6.06% | 3.88 | 3.75 | 4.00 | 4.13 | 3.88 | 4.13 | 417,971 | 12:55:55 |
| Industrial Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) | RN | NRN |
|---|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 1.8 | -4.6 | 0.0 | - | 13.72 |
Summit Corp ChartsSummit Corp Share Price |
|
Summit Corp Monthly Chart |
Summit Corp Intraday Chart |
| Type | Size | Price | Date | Time | Currency |
|---|---|---|---|---|---|
| O | 21,084 | 3.91 | 22 May 2013 | 13:23:55 | GBX |
| Posted | Poster | Post | |
|---|---|---|---|
| 15 May 2013 | harvey haddock | Good find that calmtrader and agree entirely poseidon. She will finish off what she has started with DMD successfully and when that happens there will be a Nobel prize coming her way, of that I have no doubt. read more... | |
| Sat 22:19 | vwnige | sorry monkey.. there will be no placing read more... | |
| Sat 08:18 | moneymunch | “Right now, I think the market is incompletely valuing it on its lead indication, this 15% of DMD subset, but if you begin to think about, and have a little bit of imagination about, other forms of Duchenne muscular dystrophy and other diseases, this becomes one of the most significant technology platforms that biotech has seen in a number of years,” Kuruvilla said. “This can be one of the... read more... | |
| 15 May 2013 | moneymunch | 6p plus ....get in now! GL read more... |
 |
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's |
| 1 site:2 130522 13:49 |
